Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial

Abstract Background The chronic and progressive nature of chronic obstructive pulmonary disease (COPD) requires self-administration of inhaled medication. Dry powder inhalers (DPIs) are increasingly being used for inhalation therapy in COPD. Important considerations when selecting DPIs include inhal...

Full description

Bibliographic Details
Main Authors: Pablo Altman, Luis Wehbe, Juergen Dederichs, Tadhg Guerin, Brian Ament, Miguel Cardenas Moronta, Andrea Valeria Pino, Pankaj Goyal
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Pulmonary Medicine
Subjects:
Peak inspiratory flow
Inspiratory effort
Dry powder inhalers
Pressure drop
Breezhaler®
Online Access:http://link.springer.com/article/10.1186/s12890-018-0662-0

Internet

http://link.springer.com/article/10.1186/s12890-018-0662-0

Similar Items